Earnings Preview: Panbela Therapeutics
Portfolio Pulse from Benzinga Insights
Panbela Therapeutics (NASDAQ:PBLA) is scheduled to release its quarterly earnings report on March 26, 2024, with an estimated EPS of $-24.34. Historical data shows mixed reactions to past earnings reports, with the last quarter missing EPS estimates and resulting in a 2.66% share price increase the following day. Over the past year, PBLA shares have declined by 99.79%, indicating significant investor concern ahead of this earnings announcement.
March 25, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Panbela Therapeutics is expected to report an EPS of $-24.34 for the upcoming quarter. Historical performance shows mixed reactions to earnings reports, with a significant overall decline in share price over the past year.
Given the historical mixed reactions to Panbela Therapeutics' earnings reports and the significant decline in share price over the past year, the short-term impact of the upcoming earnings report is uncertain. While a positive earnings surprise could provide a short-term boost, the overall negative trend and investor sentiment may limit gains.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100